Invacare Corp (IVC) 11.80 $IVC
Invacare Corporation Announces Changes to Its Board of Directors
BusinessWire - Thu Jul 28, 5:34AM CDT
Invacare Corporation (NYSE: IVC) today announced upcoming changes to its board of directors. General James L. Jones, who joined the board in 2010, has decided to step down effective August 26, 2016, as a result of his increasing global responsibilities and travel for his other professional roles. In addition, after 30 years of board service, Michael F. Delaney has expressed his intent not to stand for re-election when his term expires at the company's 2017 annual meeting.
IVC: 11.80 (-0.02)
Invacare Corporation Announces Financial Results for the Second Quarter and First Six Months of 2016
BusinessWire - Thu Jul 28, 5:30AM CDT
Invacare Corporation (NYSE: IVC) today announced its financial results for the second quarter and first six months ended June 30, 2016.
IVC: 11.80 (-0.02)
North America Mobility Aids & Transportation Equipment Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Invacare, Stryker, Permobil - Research and Markets
BusinessWire - Fri Jul 15, 2:46PM CDT
Research and Markets has announced the addition of the "North America Mobility Aids and Transportation Equipment Market Outlook to 2021" report to their offering.
IVC: 11.80 (-0.02)
United States Mobility Aids and Transportation Equipment Market Outlook to 2021 - Key Players are Stryker, Invacare & Hill-Rom Holdings - Research and Markets
BusinessWire - Tue Jun 21, 12:13PM CDT
Research and Markets has announced the addition of the "United States Mobility Aids and Transportation Equipment Market Outlook to 2021" report to their offering.
IVC: 11.80 (-0.02), HRC: 53.84 (-0.18)
Invacare Corporation to Present at Jefferies 2016 Healthcare Conference
BusinessWire - Thu May 26, 4:00PM CDT
Matthew E. Monaghan, Chairman, President and Chief Executive Officer, and Dean J. Childers, Senior Vice President and General Manager, North America, of Invacare Corporation (NYSE: IVC), will present at the Jefferies 2016 Healthcare Conference in New York City on Wednesday, June 8, 2016 at 8:00 am ET.
IVC: 11.80 (-0.02)
Invacare Corp Enters Oversold Territory (IVC)
MarketNewsVideo.com - Fri May 20, 10:55AM CDT
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative...
IVC: 11.80 (-0.02)
Invacare Declares Quarterly Dividend
BusinessWire - Thu May 19, 11:25AM CDT
The Board of Directors of Invacare Corporation (NYSE:IVC) announced that it declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable July 13, 2016 to shareholders of record on July 5, 2016.
IVC: 11.80 (-0.02)
Global Wheelchair Medical Equipment Market Report 2006-2016 - Analysis, Technologies & Forecasts - Key Vendors: Handicare, Invacare, LEVO - Research and Markets
BusinessWire - Tue May 17, 6:37AM CDT
Research and Markets has announced the addition of Wintergreen Research, Inc's new report "Wheelchair Medical Equipment Markets Market Share Analysis: Market Shares, Analysis, and Index, Worldwide, 2006 to Current, Quarterly" to their offering.
IVC: 11.80 (-0.02)
Invacare reports 1Q loss
Automated Insights - Thu Apr 28, 6:57AM CDT
ELYRIA, Ohio (AP) _ Invacare Corp. (IVC) on Thursday reported a loss of $8.6 million in its first quarter.
IVC: 11.80 (-0.02)
Invacare Corporation Announces Financial Results for the First Quarter of 2016
BusinessWire - Thu Apr 28, 5:30AM CDT
Invacare Corporation (NYSE: IVC) today announced its financial results for the quarter ended March 31, 2016.
IVC: 11.80 (-0.02)
18.7% Return Seen to Date on SmarTrend Invacare Call (IVC)
Comtex SmarTrend(R) - Mon Feb 08, 5:38PM CST
SmarTrend identified a Downtrend for Invacare (NYSE:IVC) on December 15th, 2015 at $17.92. In approximately 2 months, Invacare has returned 18.73% as of today's recent price of $14.56.
IVC: 11.80 (-0.02)
Invacare Down 14.9% Since SmarTrend Downtrend Call (IVC)
Comtex SmarTrend(R) - Mon Feb 01, 11:53AM CST
SmarTrend identified a Downtrend for Invacare (NYSE:IVC) on December 15th, 2015 at $17.92. In approximately 2 months, Invacare has returned 14.93% as of today's recent price of $15.24.
IVC: 11.80 (-0.02)
Invacare Corporation to Announce Financial Results for Fourth Quarter and Year Ended December 31, 2015
BusinessWire - Thu Jan 21, 5:07PM CST
Invacare Corporation (NYSE: IVC) (''Invacare'' or the ''company''
announces that it will release its financial results for the quarter and year ended December 31, 2015, before the market opens on Thursday, February 11, 2016. The company will sponsor a conference call for investors and other interested parties on Thursday, February 11, at 8:30 AM ET to discuss the company's performance.
IVC: 11.80 (-0.02)
Invacare Chairman and Chief Executive Officer Presenting at CJS Securities Conference
BusinessWire - Tue Dec 29, 4:00PM CST
Matthew E. Monaghan, Chairman, President and Chief Executive Officer, of Invacare Corporation (NYSE: IVC), will present at the Sixteenth Annual CJS Securities "New Ideas for the New Year" Investor Conference in New York on Wednesday, January 13, 2016.
IVC: 11.80 (-0.02)
Global Respiratory Devices Market Growth, Trends & Forecasts (2014 - 2020) - Expected to Reach $18 Billion By 2020
M2 - Fri Dec 18, 8:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/qqbfns/global) has announced the addition of the "Global Respiratory Devices Market Growth, Trends & Forecasts (2014 - 2020)" report to their offering. The Global market for Respiratory Devices is expected to reach $18 billion by the end of 2020 growing at a CAGR of around 11.94% from 2014 to 2020. This escalation has generated the need to analyze, review and to forecast the growth of the medical respiratory device market. Owing to the rapid evolution of market in the use of CPAP devices, medical device companies which are able to launch new innovative equipment will be awarded with huge benefits. Need of home healthcare devices has opened the gates for the respiratory devices market. The study clarifies that the CPAP devices currently dominate the respiratory device market and are expected to dominate in the future also. North America currently dominates the market for medical aesthetic devices and is expected to continue its strong hold for a few more years. Asia Pacific region is expected to increase its market share in the future owing to the increase in technological advancements in respiratory device market. Rising incidence of Chronic Obtrusive Pulmonary Disease, increase in the technological advancements, increased disposable income in developing nations are the major factors driving the growth of the respiratory devices market. Expensive devices and increased sophistication in the usage of the devices are the major challenges faced by the market. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. Porters Five Force Analysis 5. Market Segmentation 6. Respiratory Devices Market 7. Competitive Landscape 8. Company Profiles Companies Mentioned: - Resmed Inc - Airsep Corp - Alung Technologies Inc - AstraZeneca - Bomimed Inc - Carefusion Inc - Coviden PLC - Dragerwerk AG - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - GlaxoSmithKline - Intersurgical Ltd - Invacare - Masimo Corp - Phillips Healthcare - 3M - Smiths Medical - Teleflex Inc For more information visit http://www.researchandmarkets.com/research/qqbfns/global
MASI: 52.54 (-0.39), IVC: 11.80 (-0.02), TFX: 179.95 (-0.38), GSK: 45.49 (+0.24)
Invacare Up 14.7% Since SmarTrend Uptrend Call (IVC)
Comtex SmarTrend(R) - Fri Dec 11, 5:34PM CST
SmarTrend identified an Uptrend for Invacare (NYSE:IVC) on October 12th, 2015 at $16.33. In approximately 2 months, Invacare has returned 14.70% as of today's recent price of $18.73.
IVC: 11.80 (-0.02)
Medical Lifting Sling Market - Estimated to Reach USD 706.0 Million by 2020 - Lack of Skilled Training Restraining Market
M2 - Thu Dec 10, 6:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/wvcrk2/medical_lifting) has announced the addition of the "Medical Lifting Sling Market - Forecast to 2020" report to their offering. There are several factors contributing to growth in the Medical Lifting Sling Market, which is expected to reach $706.0 million by 2020. These include: - Rising geriatric population requiring assistance. - Increasing disabilities resulting from diseases like diabetes and CVD. - Government policies promoting the use of lifting slings. - High recovery cost of injuries. However, the report does take an in-depth look at the restrains in the market. It makes the assessment that there is a lack of skilled training and knowledge to handle patients. In particular, it points to the lack of knowledge with regards handling obese patients as the key factor limiting growth in the market. The medical lifting sling market is expected to grow at a double-digit CAGR of 11.4% to reach USD 706.0 Million by 2020. Report Structure: On the basis of products: - Standing slings - Seating slings - Universal slings - Hammock slings - Transfer slings - Toilet slings - Bariatric slings - Others (such as positioning and pivot slings). The transfer sling segment is expected to be the largest segment and fastest growing segment in the forecast period. This growth can be attributed to the multi-purpose usage of the sling. On the basis of usage type: - Disposable - Reusable slings. In 2015, the reusable segment will hold the largest share of the medical lifting sling market. However, the report predicts disposable slings segment will show the highest growth rate. Companies Profiled: - ETAC AB - Getinge Group (Arjohuntleigh) - Guldmann Inc. - Handicare as - Hill-Rom Holdings, Inc. - Invacare Corporation - Joerns Healthcare, LLC - Prism Medical Ltd. - Silvalea Ltd. - Spectra Care Group Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Medical Lifting Slings Market, By Product 7 Medical Lifting Slings Market, By Material 8 Medical Lifting Slings Market, By Usage Type 9 Medical Lifting Slings Market, By End User10 Medical Lifting Slings Market, By Region 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/wv...al_lifting
IVC: 11.80 (-0.02), HRC: 53.84 (-0.18)
UK Respiratory Devices Market - Growth, Trends & Forecast (2015-2020)
M2 - Wed Dec 09, 4:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/nklxrn/uk_respiratory) has announced the addition of the "UK Respiratory Devices Market - Growth, Trends & Forecast (2015-2020)" report to their offering. The major trend driving the Respiratory Devices market is the rising incidence of Chronic Obtrusive Pulmonary Disease population. The UK Respiratory Device market is currently estimated to be valued as $0.566 billion for the year 2014 and is expected to reach $0.999 billion by the end of 2019. The CAGR during this period of forecast is estimated to be 12.02%. This escalation is developing the need to analyze, review and to forecast the growth of the medical aesthetic device market. Owing to the rapid evolution of market in the use of CPAP devices, medical device companies which are able to launch new innovative equipment will be awarded with huge benefits. Drivers Large patient population, increase in the technological advancements, increased disposable income in developing nations are the major factors driving the growth of the respiratory devices market. Challenges Expensive devices and increased sophistication in the usage of the devices are the major challenges faced by the respiratory devices. The market share of each region is analyzed and estimates are provided for the next 5 years. The various applications of respiratory devices have been discussed in detail in addition to a comprehensive overview of the market. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. Porters Five Force Analysis 5. Market Segmentation 6. Medical Devices Market - By Type 7. Competitive Landscape 8. Company Profiles - Resmed Inc - Airsep Corp - Alung Technologies Inc - AstraZeneca - Bomimed Inc - Carefusion Inc - Coviden PLC - Dragerwerk AG - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - Intersurgical Ltd - Invacare - Masimo Corp - Phillips Healthcare - 3M - Smiths Medical - Teleflex Inc For more information visit http://www.researchandmarkets.com/research/nk...espiratory
MASI: 52.54 (-0.39), IVC: 11.80 (-0.02), TFX: 179.95 (-0.38)
Continuous Positive Airway Pressure Devices Market 2016-2020
M2 - Mon Dec 07, 3:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/fdxm3v/continuous) has announced the addition of the "Continuous Positive Airway Pressure Devices Market 2016-2020" report to their offering. The global continuous positive airway pressure devices market is just budding and offers high growth opportunity, and hence is expected to progress with steady growth, posting a CAGR of nearly 7% during the forecast period. One of the major drivers of the market is high prevalence of sleep disorders. It is estimated that over 350 million people worldwide suffer from sleep apnea. Thus, the increasing awareness of sleep apnea and associated comorbid conditions such as high blood pressure, and obesity have led to increased demand for sleep apnea diagnostic and therapeutic devices. Similarly, advances in technology such as improved mask design, oral appliances, and use of oxygen devices are expected to provide support to continuous positive airway pressure users. A CPAP device is used to maintain a continuous level of PAP and is used to treat preterm babies whose lungs have not yet fully developed. CPAP devices comply with all age groups and are cost-effective, simple, and easy to use. This segment dominated the market with total market share of nearly 56% in 2015. The continuous positive airway pressure devices market is currently dominated by the Americas, accounting for a market share of almost 59%, followed by the EMEA region and the APAC region. In the Americas, the US was the largest revenue contributor because of the increased diagnosis of sleep apnea in patients. Key Topics Covered: PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Sleep apnea: An overview PART 06: Diseases linked to sleep apnea PART 07: Market landscape PART 08: Market segmentation by product type PART 09: Global CPAP devices market PART 10: Global CPAP accessories market PART 11: Geographical segmentation PART 12: Market drivers PART 13: Impact of drivers PART 14: Market challenges PART 15: Impact of drivers and challenges PART 16: Market trends PART 17: Vendor landscape PART 18: Key vendor analysis - ResMed - Philips Healthcare - Fisher & Paykel - 3B Medical - Apex Medical - Apria Healthcare - Armstrong Medical - BMC Medical - Bremed - Cardinal Health - Curative Medical - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Genstar Technologies - Hans Rudolph - Heinen Lowenstein - Hersill - Heyer Medical - HOFFRICHTER GmbH - InnoMed Technologies - Intersurgical - Invacare - Medtronic - PAHSCO - Penlon - Pneumocare - Pulmodyne - Sleepnet - Smiths Medical - SOMNETICS - Sturdy Industrial - Weinmann Gerate fur Medizin. For more information visit http://www.researchandmarkets.com/research/fdxm3v/continuous
DHRM: 1.70 (-0.09), MDT: 87.64 (-0.42), IVC: 11.80 (-0.02)
Invacare Has Returned 17.6% Since SmarTrend Recommendation (IVC)
Comtex SmarTrend(R) - Fri Dec 04, 12:18PM CST
SmarTrend identified an Uptrend for Invacare (NYSE:IVC) on October 12th, 2015 at $16.33. In approximately 2 months, Invacare has returned 17.64% as of today's recent price of $19.21.
IVC: 11.80 (-0.02)
Invacare Corporation Announces Changes to Its Board of Directors
BusinessWire - Thu Jul 28, 5:34AM CDT
Invacare Corporation (NYSE: IVC) today announced upcoming changes to its board of directors. General James L. Jones, who joined the board in 2010, has decided to step down effective August 26, 2016, as a result of his increasing global responsibilities and travel for his other professional roles. In addition, after 30 years of board service, Michael F. Delaney has expressed his intent not to stand for re-election when his term expires at the company's 2017 annual meeting.
IVC: 11.80 (-0.02)
Invacare Corporation Announces Financial Results for the Second Quarter and First Six Months of 2016
BusinessWire - Thu Jul 28, 5:30AM CDT
Invacare Corporation (NYSE: IVC) today announced its financial results for the second quarter and first six months ended June 30, 2016.
IVC: 11.80 (-0.02)
North America Mobility Aids & Transportation Equipment Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Invacare, Stryker, Permobil - Research and Markets
BusinessWire - Fri Jul 15, 2:46PM CDT
Research and Markets has announced the addition of the "North America Mobility Aids and Transportation Equipment Market Outlook to 2021" report to their offering.
IVC: 11.80 (-0.02)
United States Mobility Aids and Transportation Equipment Market Outlook to 2021 - Key Players are Stryker, Invacare & Hill-Rom Holdings - Research and Markets
BusinessWire - Tue Jun 21, 12:13PM CDT
Research and Markets has announced the addition of the "United States Mobility Aids and Transportation Equipment Market Outlook to 2021" report to their offering.
IVC: 11.80 (-0.02), HRC: 53.84 (-0.18)
Invacare Corporation to Present at Jefferies 2016 Healthcare Conference
BusinessWire - Thu May 26, 4:00PM CDT
Matthew E. Monaghan, Chairman, President and Chief Executive Officer, and Dean J. Childers, Senior Vice President and General Manager, North America, of Invacare Corporation (NYSE: IVC), will present at the Jefferies 2016 Healthcare Conference in New York City on Wednesday, June 8, 2016 at 8:00 am ET.
IVC: 11.80 (-0.02)
Invacare Corp Enters Oversold Territory (IVC)
MarketNewsVideo.com - Fri May 20, 10:55AM CDT
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative...
IVC: 11.80 (-0.02)
Invacare Declares Quarterly Dividend
BusinessWire - Thu May 19, 11:25AM CDT
The Board of Directors of Invacare Corporation (NYSE:IVC) announced that it declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable July 13, 2016 to shareholders of record on July 5, 2016.
IVC: 11.80 (-0.02)
Global Wheelchair Medical Equipment Market Report 2006-2016 - Analysis, Technologies & Forecasts - Key Vendors: Handicare, Invacare, LEVO - Research and Markets
BusinessWire - Tue May 17, 6:37AM CDT
Research and Markets has announced the addition of Wintergreen Research, Inc's new report "Wheelchair Medical Equipment Markets Market Share Analysis: Market Shares, Analysis, and Index, Worldwide, 2006 to Current, Quarterly" to their offering.
IVC: 11.80 (-0.02)
Invacare reports 1Q loss
Automated Insights - Thu Apr 28, 6:57AM CDT
ELYRIA, Ohio (AP) _ Invacare Corp. (IVC) on Thursday reported a loss of $8.6 million in its first quarter.
IVC: 11.80 (-0.02)
Invacare Corporation Announces Financial Results for the First Quarter of 2016
BusinessWire - Thu Apr 28, 5:30AM CDT
Invacare Corporation (NYSE: IVC) today announced its financial results for the quarter ended March 31, 2016.
IVC: 11.80 (-0.02)
18.7% Return Seen to Date on SmarTrend Invacare Call (IVC)
Comtex SmarTrend(R) - Mon Feb 08, 5:38PM CST
SmarTrend identified a Downtrend for Invacare (NYSE:IVC) on December 15th, 2015 at $17.92. In approximately 2 months, Invacare has returned 18.73% as of today's recent price of $14.56.
IVC: 11.80 (-0.02)
Invacare Down 14.9% Since SmarTrend Downtrend Call (IVC)
Comtex SmarTrend(R) - Mon Feb 01, 11:53AM CST
SmarTrend identified a Downtrend for Invacare (NYSE:IVC) on December 15th, 2015 at $17.92. In approximately 2 months, Invacare has returned 14.93% as of today's recent price of $15.24.
IVC: 11.80 (-0.02)
Invacare Corporation to Announce Financial Results for Fourth Quarter and Year Ended December 31, 2015
BusinessWire - Thu Jan 21, 5:07PM CST
Invacare Corporation (NYSE: IVC) (''Invacare'' or the ''company''
announces that it will release its financial results for the quarter and year ended December 31, 2015, before the market opens on Thursday, February 11, 2016. The company will sponsor a conference call for investors and other interested parties on Thursday, February 11, at 8:30 AM ET to discuss the company's performance. IVC: 11.80 (-0.02)
Invacare Chairman and Chief Executive Officer Presenting at CJS Securities Conference
BusinessWire - Tue Dec 29, 4:00PM CST
Matthew E. Monaghan, Chairman, President and Chief Executive Officer, of Invacare Corporation (NYSE: IVC), will present at the Sixteenth Annual CJS Securities "New Ideas for the New Year" Investor Conference in New York on Wednesday, January 13, 2016.
IVC: 11.80 (-0.02)
Global Respiratory Devices Market Growth, Trends & Forecasts (2014 - 2020) - Expected to Reach $18 Billion By 2020
M2 - Fri Dec 18, 8:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/qqbfns/global) has announced the addition of the "Global Respiratory Devices Market Growth, Trends & Forecasts (2014 - 2020)" report to their offering. The Global market for Respiratory Devices is expected to reach $18 billion by the end of 2020 growing at a CAGR of around 11.94% from 2014 to 2020. This escalation has generated the need to analyze, review and to forecast the growth of the medical respiratory device market. Owing to the rapid evolution of market in the use of CPAP devices, medical device companies which are able to launch new innovative equipment will be awarded with huge benefits. Need of home healthcare devices has opened the gates for the respiratory devices market. The study clarifies that the CPAP devices currently dominate the respiratory device market and are expected to dominate in the future also. North America currently dominates the market for medical aesthetic devices and is expected to continue its strong hold for a few more years. Asia Pacific region is expected to increase its market share in the future owing to the increase in technological advancements in respiratory device market. Rising incidence of Chronic Obtrusive Pulmonary Disease, increase in the technological advancements, increased disposable income in developing nations are the major factors driving the growth of the respiratory devices market. Expensive devices and increased sophistication in the usage of the devices are the major challenges faced by the market. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. Porters Five Force Analysis 5. Market Segmentation 6. Respiratory Devices Market 7. Competitive Landscape 8. Company Profiles Companies Mentioned: - Resmed Inc - Airsep Corp - Alung Technologies Inc - AstraZeneca - Bomimed Inc - Carefusion Inc - Coviden PLC - Dragerwerk AG - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - GlaxoSmithKline - Intersurgical Ltd - Invacare - Masimo Corp - Phillips Healthcare - 3M - Smiths Medical - Teleflex Inc For more information visit http://www.researchandmarkets.com/research/qqbfns/global
MASI: 52.54 (-0.39), IVC: 11.80 (-0.02), TFX: 179.95 (-0.38), GSK: 45.49 (+0.24)
Invacare Up 14.7% Since SmarTrend Uptrend Call (IVC)
Comtex SmarTrend(R) - Fri Dec 11, 5:34PM CST
SmarTrend identified an Uptrend for Invacare (NYSE:IVC) on October 12th, 2015 at $16.33. In approximately 2 months, Invacare has returned 14.70% as of today's recent price of $18.73.
IVC: 11.80 (-0.02)
Medical Lifting Sling Market - Estimated to Reach USD 706.0 Million by 2020 - Lack of Skilled Training Restraining Market
M2 - Thu Dec 10, 6:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/wvcrk2/medical_lifting) has announced the addition of the "Medical Lifting Sling Market - Forecast to 2020" report to their offering. There are several factors contributing to growth in the Medical Lifting Sling Market, which is expected to reach $706.0 million by 2020. These include: - Rising geriatric population requiring assistance. - Increasing disabilities resulting from diseases like diabetes and CVD. - Government policies promoting the use of lifting slings. - High recovery cost of injuries. However, the report does take an in-depth look at the restrains in the market. It makes the assessment that there is a lack of skilled training and knowledge to handle patients. In particular, it points to the lack of knowledge with regards handling obese patients as the key factor limiting growth in the market. The medical lifting sling market is expected to grow at a double-digit CAGR of 11.4% to reach USD 706.0 Million by 2020. Report Structure: On the basis of products: - Standing slings - Seating slings - Universal slings - Hammock slings - Transfer slings - Toilet slings - Bariatric slings - Others (such as positioning and pivot slings). The transfer sling segment is expected to be the largest segment and fastest growing segment in the forecast period. This growth can be attributed to the multi-purpose usage of the sling. On the basis of usage type: - Disposable - Reusable slings. In 2015, the reusable segment will hold the largest share of the medical lifting sling market. However, the report predicts disposable slings segment will show the highest growth rate. Companies Profiled: - ETAC AB - Getinge Group (Arjohuntleigh) - Guldmann Inc. - Handicare as - Hill-Rom Holdings, Inc. - Invacare Corporation - Joerns Healthcare, LLC - Prism Medical Ltd. - Silvalea Ltd. - Spectra Care Group Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Medical Lifting Slings Market, By Product 7 Medical Lifting Slings Market, By Material 8 Medical Lifting Slings Market, By Usage Type 9 Medical Lifting Slings Market, By End User10 Medical Lifting Slings Market, By Region 11 Company Profiles For more information visit http://www.researchandmarkets.com/research/wv...al_lifting
IVC: 11.80 (-0.02), HRC: 53.84 (-0.18)
UK Respiratory Devices Market - Growth, Trends & Forecast (2015-2020)
M2 - Wed Dec 09, 4:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/nklxrn/uk_respiratory) has announced the addition of the "UK Respiratory Devices Market - Growth, Trends & Forecast (2015-2020)" report to their offering. The major trend driving the Respiratory Devices market is the rising incidence of Chronic Obtrusive Pulmonary Disease population. The UK Respiratory Device market is currently estimated to be valued as $0.566 billion for the year 2014 and is expected to reach $0.999 billion by the end of 2019. The CAGR during this period of forecast is estimated to be 12.02%. This escalation is developing the need to analyze, review and to forecast the growth of the medical aesthetic device market. Owing to the rapid evolution of market in the use of CPAP devices, medical device companies which are able to launch new innovative equipment will be awarded with huge benefits. Drivers Large patient population, increase in the technological advancements, increased disposable income in developing nations are the major factors driving the growth of the respiratory devices market. Challenges Expensive devices and increased sophistication in the usage of the devices are the major challenges faced by the respiratory devices. The market share of each region is analyzed and estimates are provided for the next 5 years. The various applications of respiratory devices have been discussed in detail in addition to a comprehensive overview of the market. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. Porters Five Force Analysis 5. Market Segmentation 6. Medical Devices Market - By Type 7. Competitive Landscape 8. Company Profiles - Resmed Inc - Airsep Corp - Alung Technologies Inc - AstraZeneca - Bomimed Inc - Carefusion Inc - Coviden PLC - Dragerwerk AG - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - Intersurgical Ltd - Invacare - Masimo Corp - Phillips Healthcare - 3M - Smiths Medical - Teleflex Inc For more information visit http://www.researchandmarkets.com/research/nk...espiratory
MASI: 52.54 (-0.39), IVC: 11.80 (-0.02), TFX: 179.95 (-0.38)
Continuous Positive Airway Pressure Devices Market 2016-2020
M2 - Mon Dec 07, 3:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/fdxm3v/continuous) has announced the addition of the "Continuous Positive Airway Pressure Devices Market 2016-2020" report to their offering. The global continuous positive airway pressure devices market is just budding and offers high growth opportunity, and hence is expected to progress with steady growth, posting a CAGR of nearly 7% during the forecast period. One of the major drivers of the market is high prevalence of sleep disorders. It is estimated that over 350 million people worldwide suffer from sleep apnea. Thus, the increasing awareness of sleep apnea and associated comorbid conditions such as high blood pressure, and obesity have led to increased demand for sleep apnea diagnostic and therapeutic devices. Similarly, advances in technology such as improved mask design, oral appliances, and use of oxygen devices are expected to provide support to continuous positive airway pressure users. A CPAP device is used to maintain a continuous level of PAP and is used to treat preterm babies whose lungs have not yet fully developed. CPAP devices comply with all age groups and are cost-effective, simple, and easy to use. This segment dominated the market with total market share of nearly 56% in 2015. The continuous positive airway pressure devices market is currently dominated by the Americas, accounting for a market share of almost 59%, followed by the EMEA region and the APAC region. In the Americas, the US was the largest revenue contributor because of the increased diagnosis of sleep apnea in patients. Key Topics Covered: PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Sleep apnea: An overview PART 06: Diseases linked to sleep apnea PART 07: Market landscape PART 08: Market segmentation by product type PART 09: Global CPAP devices market PART 10: Global CPAP accessories market PART 11: Geographical segmentation PART 12: Market drivers PART 13: Impact of drivers PART 14: Market challenges PART 15: Impact of drivers and challenges PART 16: Market trends PART 17: Vendor landscape PART 18: Key vendor analysis - ResMed - Philips Healthcare - Fisher & Paykel - 3B Medical - Apex Medical - Apria Healthcare - Armstrong Medical - BMC Medical - Bremed - Cardinal Health - Curative Medical - Dehaier Medical Systems - DeVilbiss Healthcare - Drager Medical - Genstar Technologies - Hans Rudolph - Heinen Lowenstein - Hersill - Heyer Medical - HOFFRICHTER GmbH - InnoMed Technologies - Intersurgical - Invacare - Medtronic - PAHSCO - Penlon - Pneumocare - Pulmodyne - Sleepnet - Smiths Medical - SOMNETICS - Sturdy Industrial - Weinmann Gerate fur Medizin. For more information visit http://www.researchandmarkets.com/research/fdxm3v/continuous
DHRM: 1.70 (-0.09), MDT: 87.64 (-0.42), IVC: 11.80 (-0.02)
Invacare Has Returned 17.6% Since SmarTrend Recommendation (IVC)
Comtex SmarTrend(R) - Fri Dec 04, 12:18PM CST
SmarTrend identified an Uptrend for Invacare (NYSE:IVC) on October 12th, 2015 at $16.33. In approximately 2 months, Invacare has returned 17.64% as of today's recent price of $19.21.
IVC: 11.80 (-0.02)
